Alpha-7 nicotinic receptor

From WikiMD's Wellness Encyclopedia

Alpha-7 Nicotinic Receptor[edit | edit source]

The alpha-7 nicotinic receptor (α7 nAChR) is a type of nicotinic acetylcholine receptor that is predominantly found in the central nervous system and is known for its role in modulating neurotransmission. This receptor is a ligand-gated ion channel that is activated by the neurotransmitter acetylcholine as well as by nicotine.

Structure[edit | edit source]

The α7 nicotinic receptor is a homopentamer, meaning it is composed of five identical subunits. Each subunit has four transmembrane domains and a large extracellular domain that contains the acetylcholine binding site. The receptor is permeable to cations, including calcium ions, which play a crucial role in intracellular signaling pathways.

Function[edit | edit source]

The primary function of the α7 nicotinic receptor is to mediate fast synaptic transmission in the nervous system. It is involved in several physiological processes, including:

  • **Cognitive Function**: The α7 receptor is implicated in learning and memory. It is thought to enhance cognitive processes by modulating the release of neurotransmitters such as glutamate and dopamine.
  • **Neuroprotection**: Activation of α7 receptors has been shown to protect neurons from apoptosis and neurodegeneration.
  • **Inflammation**: The α7 receptor plays a role in the "cholinergic anti-inflammatory pathway," which helps regulate the body's immune response.

Clinical Significance[edit | edit source]

The α7 nicotinic receptor is a target for drug development due to its involvement in various neurological and psychiatric disorders. Some of the conditions associated with α7 receptor dysfunction include:

  • **Schizophrenia**: Reduced expression of α7 receptors has been observed in patients with schizophrenia, and agonists of the receptor are being investigated as potential treatments.
  • **Alzheimer's Disease**: The receptor is a target for therapeutic agents aimed at improving cognitive function in Alzheimer's patients.
  • **Inflammatory Diseases**: Due to its role in modulating inflammation, α7 receptor agonists are being explored for the treatment of inflammatory conditions.

Research[edit | edit source]

Ongoing research is focused on understanding the precise mechanisms by which the α7 nicotinic receptor influences neural circuits and behavior. Studies are also exploring the development of selective agonists and antagonists that can modulate receptor activity with minimal side effects.

Also see[edit | edit source]


WikiMD
Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD

Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD

WikiMD's Wellness Encyclopedia

Let Food Be Thy Medicine
Medicine Thy Food - Hippocrates

Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.

Contributors: Prab R. Tumpati, MD